Company: ICUI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000883984-25-000007
Chunk: 319

Company: ICU MEDICAL INC/DE
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 319
---
82,356)(66,734)Net cash provided by (used in) operating activities204,033 166,201 (62,129)CASH FLOWS FROM INVESTING ACTIVITIES:  Purchases of property, plant and equipment(79,373)(83,893)(90,311)Proceeds from sale of assets746 1,501 989 Intangible asset additions(10,833)(9,777)(9,018)Business acquisitions, net of cash acquired— — (1,844,164)Purchases of investment securities— — (3,397)Proceeds from sale of investment securities500 4,222 36,433 Net cash used in investing activities(88,960)(87,947)(1,909,468)CASH FLOWS FROM FINANCING ACTIVITIES:  Proceeds from issuance of long-term debt, net of lender debt issuance costs— — 1,664,362 Principal repayments of long-term debt(51,000)(29,688)(22,375)Payment of third-party debt issuance costs— — (2,177)Proceeds from exercise of stock options10,939 4,022 8,785 Payments on finance leases(1,147)(963)(680)Payment of contingent earn-out(2,600)— — Tax withholding payments related to net share settlement of equity awards(11,992)(9,350)(10,883)Net cash (used in) provided by financing activities(55,800)(35,979)1,637,032 Effect of exchange rate changes on cash(4,929)3,163 (9,478)NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS54,344 45,438 (344,043)CASH AND CASH EQUIVALENTS, beginning of period254,222 208,784 552,827 CASH AND CASH EQUIVALENTS, end of period$308,566 $254,222 $208,784 

 The accompanying notes are an integral part of these consolidated financial statements.

66

ICU MEDICAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED

(Amounts in thousands)

Year ended December 31,202420232022SUPPLEMENTAL